| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology (S.-H.L., W.-S.R., J.-K.R.) and Clinical Research Center for Stroke, Clinical Research Institute (S.-H.L.), Seoul National University Hospital, Seoul, Republic of Korea.
Address correspondence and reprint requests to Dr. Jae-Kyu Roh, Department of Neurology, Seoul National University Hospital, 28 Yongon-dong, Jongno-gu, Seoul, 110-744, Republic of Korea rohjk{at}snu.ac.kr
Background: Cerebral microbleeds are known to be indicative of bleeding-prone microangiopathy and may predict incident intracerebral hemorrhage (ICH). In this study, we investigated whether microbleeds are associated with the incidence of warfarin-related ICH.
Methods: Twenty-four patients with ICH while on outpatient treatment with warfarin were selected from a consecutive cohort. Control, warfarin-using subjects with no history of ICH were randomly selected during the same time period (n = 48). We compared demographic factors, vascular risk factors, laboratory findings, and radiologic findings including microbleeds between the groups.
Result: There were more cases of patients with microbleeds in the ICH than control group (79.2% vs 22.9%: p < 0.001), and the number of microbleeds was much higher for the ICH group (9.0 ± 26.8 vs 0.5 ± 1.03: p < 0.001). Moreover, the number of microbleeds was significantly correlated with the presence of warfarin-related ICH (r = 0.299; p < 0.001). Conditional logistic regression analysis showed that increased prothrombin time and the presence of microbleeds were independently related to the incidence of warfarin-related ICH (microbleeds: adjusted OR, 83.12).
Conclusion: This study suggests that underlying microbleeds are independently associated with an incidence of warfarin-related intracerebral hemorrhage. Future research should focus on elucidating the risks and benefits of warfarin medication in patients with microbleeds.
Abbreviations: CI = confidence interval; GRE = gradient-echo; ICH = intracerebral hemorrhage; INR = international normalized ratio; NS = not significant; OR = odds ratio; PT = prothrombin time; WMH = white matter hyperintensity.
*These authors contributed equally.
Supported by grants of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (A060143, A060171, and A060263).
Disclosure: The authors report no disclosures.
Supplemental data at www.neurology.org
Received April 21, 2008. Accepted in final form October 3, 2008.
This article has been cited by other articles:
|
|
 |
|
  S. M. Gregoire, U. J. Chaudhary, M. M. Brown, T. A. Yousry, C. Kallis, H. R. Jager, and D. J. Werring The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds Neurology, November 24, 2009; 73(21): 1759 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Orken, G. Kenangil, E. Uysal, and H. Forta Cerebral Microbleeds in Ischemic Stroke Patients on Warfarin Treatment Stroke, November 1, 2009; 40(11): 3638 - 3640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Klein, B. Iung, J. Labreuche, A. Hess, M. Wolff, D. Messika-Zeitoun, P. Lavallee, J.-P. Laissy, C. Leport, X. Duval, et al. Cerebral Microbleeds Are Frequent in Infective Endocarditis: A Case-Control Study Stroke, November 1, 2009; 40(11): 3461 - 3465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Cerebral Microbleeds and Warfarin-Related Hemorrhage Journal Watch Neurology, March 31, 2009; 2009(331): 1 - 1. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
